CX 2021 Programme

Peripheral Arterial Proximal Controversies - Tuesday, 20th April
Venue:   Livestream 1
Time: 14:00 - 19:30
Paclitaxel-coated device controversies
Moderators:   Andrew Holden, Auckland, New Zealand
Gunnar Tepe, Rosenheim, Germany
Five-year mortality in the REAL-PTX study
Speaker:   Sabine Steiner, Leipzig, Germany
Latest analysis and interpretation of SWEDEPAD trial concerning mortality
Speaker:   Mårten Falkenberg, Gothenburg, Sweden
Limus is the better drug for prevention of restenosis in peripheral interventions
Speaker:   Edward Choke, Singapore, Singapore
Clinical evaluation and regulatory approaches to next-generation drug-coated devices for peripheral arterial disease
Speaker:   Sara Royce, FDA, Silver Spring, United States
It is time to change the agency recommendations regarding paclitaxel use in peripheral interventions
Speaker:   Thomas Zeller, Bad Krozingen, Germany
 
Networking break
Podium 1st miscellaneous controversies
Moderators:   Thomas Zeller, Bad Krozingen, Germany
Robert Hinchliffe, Bristol, United Kingdom
Podium 1st: Five-year meta-analysis including mortality update with FDA-approved RCTs of paclitaxel devices
Speaker:   Andrew Holden, Auckland, New Zealand
Podium 1st: IVUS vs. angiography-guided femoropopliteal revascularisation: Twelve-month results from a randomised controlled trial
Speaker:   Phillip Puckridge, Marion, Australia
Podium 1st: Comparison of swirling flow stent and drug-eluting device outcomes
Speaker:   Peter Gaines, Sheffield, United Kingdom
Podium 1st: ZILVERPASS 36-month data update
Speaker:   Michel Bosiers, Muenster, Germany
Podium 1st: Five-year outcomes with DCB alone versus DCB plus stenting from the IN.PACT Global Study
Speaker:   Gary Ansel, Columbus, United States
Podium 1st: Five-year results from a patient-level meta-analysis of the ILLUMENATE RCTs
Speaker:   WIlliam Gray, Wynnewood, United States
 
Networking break
Reconstruction controversies
Moderators:   Thomas Zeller, Bad Krozingen, Germany
Andrew Holden, Auckland, New Zealand
FLEX study: Three-year follow-up of patients with iIliac occlusive disease treated with a balloon-expandable endoprosthesis
Speaker:   Jean Panneton, Norfolk, United States
Edited case: Complex occlusive iliac recanalisation
Speaker:   Rutger Lelij, Amsterdam, Netherlands
CX Debate: For symptomatic origin of profunda femoris artery lesions endovascular reconstruction is indicated

For the motion
Rebeca Reachi-Lugo, SAN LUIS POTOSI, Mexico

Against the motion
Robert Hinchliffe, Bristol, United Kingdom

VANQUISH trial: One-year results of heparin-bonded stent graft for femoropopliteal disease - results and factors influencing outcomes
Speaker:   Osamu Iida, Amagasaki, Japan
Edited case: Long SFA endoluminal bypass treatment for in-stent restenosis
Speaker:   Koen Deloose, Dendermonde, Belgium
 
Networking break
Calcification controversies
Moderators:   Andrew Holden, Auckland, New Zealand
Gunnar Tepe, Rosenheim, Germany
Early suspicion of calcified artery
Speaker:   Mari Murumets, London, United Kingdom
Edited case: When balloons will not pass is atherectomy the answer?
Speaker:   Richard O'Neill, Nottingham, United Kingdom
Vessel preparation for long, calcified femoropopliteal lesions with directional atherectomy and DCB: REALITY trial 12-month results
Speaker:   Krishna Rocha-Singh, Springfield, United States
Dissection repair: Evidence review and learnings from the TOBA trials
Speaker:   Michael Lichtenberg, Arnsberg, Germany